CinCor Pharma, Inc. Alternatives & Competitors

12 companies similar to CinCor Pharma, Inc. — DEVELOPING THE NEXT GENERATION OF TREATMENTS FOR CARDIO-RENAL DISEASES.

Cantex Pharmaceuticals, Inc.

Developing novel treatments of inflammatory diseases and cancer

3 Debt Financing $22.27M

Biopharma Biotechnology +1

T3 Pharmaceuticals AG

Developing the next generation bacterial cancer therapy

25 Grant $37.00M

Basel, Switzerland

Biotechnology Health and Wellness +1

Palvella Therapeutics

Developing and commercializing novel therapies for rare genetic skin diseases with no appr...

22 Series D $106.84M

Wayne, United States

Biotechnology Health Care +2

Surface Ophthalmics

Developing Next Generation Therapies for Ocular Surface Diseases

3 Venture round

Biotechnology Health Care +2

Track all CinCor Pharma, Inc. competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Caribou Biosciences

Clinical-stage biopharmaceutical company developing transformative therapies to treat deva...

128 IPO $588.55M

Berkeley, United States

Biotechnology Health Care +1

Avenzo Therapeutics

Developing the next generation of oncology therapies for patients

61 $661.00M

San Diego, United States

Biotechnology Health Care +1

Multiomic Health

AI-Enabled Precision Medicine for Cardiovascular Renal Metabolic (CRM) Disease

13 Seed $8.41M

London, United Kingdom

AI Biotechnology +3

Larimar Therapeutics Inc.

Clinical-stage biotechnology company focused on developing treatments for complex rare dis...

84 Post-IPO Equity $552.68M

United States

Biotechnology Health and Wellness

Basking Biosciences Inc

Developing a next generation solution for acute thrombolysis

8 Series A $89.80M

Columbus, United States

Biotechnology Health Care +2

Certa Therapeutics

Developing innovative precision therapies for the treatment of inflammatory and fibrotic d...

10 Grant $25.00M

Biotechnology Health and Wellness

HDAX Therapeutics

Next-gen targeting for breakthrough medicines

15 Grant $500.00K

Mississauga, Canada

Biopharma Biotechnology +2

Artax Biopharma Inc

Developing oral first-in-class Nck blockers for the treatment of T cell mediated autoimmun...

14 Venture round $67.81M

Biopharma Biotechnology +2

Frequently Asked Questions

Companies similar to CinCor Pharma, Inc. include Cantex Pharmaceuticals, Inc., T3 Pharmaceuticals AG, Palvella Therapeutics, Surface Ophthalmics, Caribou Biosciences. They work in Biotechnology and Health and Wellness.

Bounce Watch lists 12 companies that share CinCor Pharma, Inc.'s industries and are closest to it in business tags, services, target customers, business model and size.

DEVELOPING THE NEXT GENERATION OF TREATMENTS FOR CARDIOVASCULAR DISEASES.

Don't just read about them. Follow them.

BounceWatch watches CinCor Pharma, Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

CinCor Pharma, Inc. Profile Cantex Pharmaceuticals, Inc. Alternatives T3 Pharmaceuticals AG Alternatives Palvella Therapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. The 11 companies listed here were last checked between 11 Sep 2024 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.